Conference - Vancouver, Canada
The PI3K-Akt-mTOR signaling pathway is one of the primary mechanisms for controlling cell growth, survival and motility in response to intracellular signaling and extracellular cues. This meeting brings together scientists and clinicians from academia and industry to discuss the opportunities and liabilities of targeting the PI3K- and related pathways in disease, drawing on human pathophysiology and genetics, preclinical models and clinical data with PI3K pathway inhibitors. The joint meeting on "Integrating Metabolism and Tumor Biology" will enhance opportunities for interdisciplinary interactions.
Organization: Keystone Symposia
Tue, Jan 13, 2015 - Sun, Jan 18, 2015
Fairmont Vancouver Hotel
Vancouver, Canada
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
